Newbridge Financial Services Group’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3
Closed -$9 1188
2024
Q3
$9 Sell
3
-5
-63% -$22 ﹤0.01% 651
2024
Q2
$38 Hold
8
﹤0.01% 1070
2024
Q1
$60 Hold
8
﹤0.01% 1150
2023
Q4
$68 Hold
8
﹤0.01% 1095
2023
Q3
$67 Hold
8
﹤0.01% 1256
2023
Q2
$91 Sell
8
-2
-20% -$52 ﹤0.01% 1304
2023
Q1
$702 Hold
10
﹤0.01% 1301
2022
Q4
$817 Hold
10
﹤0.01% 1321
2022
Q3
$1K Hold
10
﹤0.01% 1354
2022
Q2
$2K Sell
10
-3
-23% -$710 ﹤0.01% 1234
2022
Q1
$5K Hold
13
﹤0.01% 1121
2021
Q4
$5K Hold
13
﹤0.01% 1093
2021
Q3
$10K Sell
13
-47
-78% -$39.3K 0.01% 885
2021
Q2
$63K Buy
60
+47
+362% +$56.2K 0.04% 371
2021
Q1
$19K Sell
13
-11
-46% -$16K 0.01% 714
2020
Q4
$25K Buy
24
+9
+60% +$8.18K 0.02% 488
2020
Q3
$11K Buy
+15
New +$14.3K 0.01% 660

Other funds holding YCBD

Newbridge Financial Services Group's YCBD Position: Q4 2024 in Review

Newbridge Financial Services Group sold out of cbdMD (YCBD) in Q4 2024, closing a stake of 3 shares — an estimated $9 sold.

Newbridge Financial Services Group first reported a position in YCBD in Q3 2020 and held it in 17 quarters. The position peaked at $63K in Q2 2021. 16 funds tracked by Wall St. Rank hold YCBD as of Q4 2024.

  • Newbridge Financial Services Group reported no remaining cbdMD position as of Q4 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 3 cbdMD shares in Q4 2024, an estimated $9.
  • Newbridge Financial Services Group first reported a position in cbdMD in Q3 2020 and held it in 17 quarters.
  • Newbridge Financial Services Group's cbdMD position peaked at $63K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held cbdMD as of Q4 2024.

Based on Newbridge Financial Services Group's 13F filing for Q4 2024, filed 28 Jan 2025.